1Maurey C,Hislop AA.Interaction of KATP channels and endothelin-1 in lambs with persistent pulmonary hypertension of the newborn[J].Pediatr Res,2006,60(3):252.
2Kocic I,Sztormowska K.Pulmonary hypertension modifies responsiveness of sinoatrial cells of rat hearts to adrenomimetics and activators of ATP-sensitive K+ channels in a gender-dependent way[J].J Physiol Pharmacol,2009,60(1):165.
3Fernandez SF,Tandar A.Emerging medical treatment for angina pectoris[J].Expert Opin Emerg Drugs,2010,15(2):283.
4中华医学会心血管病学分会.中国PAH筛查诊断治疗专家共识.中华心血管病杂志,2007,.
5Isomoto SC,Kondo M.A novel sulfonylurea receptor forms with BIR(Kir6.2) a smooth muscle type ATPsensitive K+ channel[J].J Biol Chem,1996,271(40):24.
6Mandegar M,Yuan JX.Role of K+ channels in pulmonary hypertension[J].Vascul Phanncol,2002,38(1):25.
7Fujita H,Ogura T.A key role for the subunit SUR2B in the preferential activation of vascular KATP channels by isoaurane[J].Br J Pharmaco1,2006,149(5):573.
8Lemos PA, Serruys PW, van Domburg RT, et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation, 2004,109:190-195.
9Moreno R, Fernandez C, Alfonso F, et al. Thrombosis after drug-eluting vs bare-metal stent implantation: a meta-analysis from 10 randomized trials including 5030 patients. Circulation, 2004,110:III-687. Abstract 3181.
10The IONA Study Group.Trial to show the impact of nicorandil in angina (IONA):design,methodology,and management.Heart,2001;85 (6):E9
